Long-term safety of ezetimibe/simvastatin as compared with simvastatin alone in patients with primary hypercholesterolaemia.

Trial Profile

Long-term safety of ezetimibe/simvastatin as compared with simvastatin alone in patients with primary hypercholesterolaemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2014

At a glance

  • Drugs Ezetimibe/simvastatin (Primary) ; Ezetimibe; Simvastatin
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top